Vertex Pharmaceuticals IncNASDAQ:VRTX
- LAST PRICE490.8500
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots490.8500/ 1
- Ask / Lots505.0000/ 1
- Open / Previous Close488.4450 / 490.8500
- Day Range
- 52 Week Range
- Volume827,658
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | VRTX |
|---|---|---|
| 09:32 ET | 19565 | 487.51 |
| 09:34 ET | 3718 | 487.075 |
| 09:36 ET | 3375 | 489.02 |
| 09:38 ET | 100 | 488.3 |
| 09:39 ET | 2880 | 490.34 |
| 09:43 ET | 2653 | 488.59 |
| 09:45 ET | 900 | 488.51 |
| 09:48 ET | 2301 | 488.85 |
| 09:50 ET | 982 | 489.27 |
| 09:52 ET | 300 | 489.125 |
| 09:54 ET | 800 | 489.46 |
| 09:56 ET | 2486 | 489.8 |
| 09:57 ET | 900 | 489.61 |
| 09:59 ET | 1600 | 489.01 |
| 10:01 ET | 1935 | 489.86 |
| 10:03 ET | 1200 | 490.21 |
| 10:06 ET | 1778 | 489.15 |
| 10:08 ET | 636 | 489.21 |
| 10:10 ET | 702 | 489.2 |
| 10:12 ET | 1808 | 489.41 |
| 10:14 ET | 2726 | 489.75 |
| 10:15 ET | 900 | 490.52 |
| 10:17 ET | 650 | 490.665 |
| 10:19 ET | 450 | 490.8 |
| 10:21 ET | 650 | 491.05 |
| 10:24 ET | 412 | 490.725 |
| 10:26 ET | 944 | 490.295 |
| 10:30 ET | 283 | 489.8142 |
| 10:32 ET | 1100 | 489.99 |
| 10:33 ET | 1200 | 490.505 |
| 10:35 ET | 700 | 490.56 |
| 10:37 ET | 200 | 490.3 |
| 10:39 ET | 1274 | 490.91 |
| 10:42 ET | 1275 | 490.97 |
| 10:44 ET | 300 | 491.09 |
| 10:46 ET | 100 | 491.38 |
| 10:48 ET | 200 | 491.505 |
| 10:50 ET | 1800 | 491.27 |
| 10:51 ET | 500 | 491.444 |
| 10:53 ET | 1000 | 490.33 |
| 10:55 ET | 800 | 490.75 |
| 10:57 ET | 1024 | 491.49 |
| 11:00 ET | 400 | 491.23 |
| 11:02 ET | 314 | 491.48 |
| 11:04 ET | 200 | 491.29 |
| 11:06 ET | 967 | 491.39 |
| 11:08 ET | 1900 | 492.295 |
| 11:09 ET | 3600 | 492.68 |
| 11:11 ET | 2284 | 492.89 |
| 11:13 ET | 600 | 492.935 |
| 11:15 ET | 500 | 492.91 |
| 11:18 ET | 1457 | 493.069 |
| 11:20 ET | 300 | 492.985 |
| 11:22 ET | 700 | 493 |
| 11:24 ET | 3000 | 493.22 |
| 11:26 ET | 700 | 493.13 |
| 11:27 ET | 1602 | 492.75 |
| 11:29 ET | 1600 | 493.005 |
| 11:31 ET | 900 | 492.75 |
| 11:33 ET | 1900 | 493.255 |
| 11:38 ET | 970 | 493.41 |
| 11:40 ET | 400 | 493.35 |
| 11:42 ET | 278 | 493.469117 |
| 11:44 ET | 1000 | 493.55 |
| 11:45 ET | 1500 | 493.5 |
| 11:47 ET | 950 | 493.63 |
| 11:49 ET | 2025 | 493.31 |
| 11:51 ET | 200 | 493.48 |
| 11:54 ET | 800 | 493.48 |
| 11:56 ET | 500 | 493.5 |
| 11:58 ET | 1790 | 493.5 |
| 12:00 ET | 100 | 493.63 |
| 12:02 ET | 701 | 493.47 |
| 12:03 ET | 600 | 493.405 |
| 12:05 ET | 1800 | 493.485 |
| 12:07 ET | 1300 | 493.305 |
| 12:09 ET | 2625 | 493.77 |
| 12:12 ET | 3020 | 493.795 |
| 12:14 ET | 1031 | 493.73 |
| 12:16 ET | 1800 | 493.425 |
| 12:18 ET | 400 | 493.405 |
| 12:20 ET | 600 | 493.5 |
| 12:23 ET | 113 | 493.5 |
| 12:25 ET | 2223 | 493.5 |
| 12:27 ET | 2729 | 493.43 |
| 12:30 ET | 500 | 493.015 |
| 12:32 ET | 700 | 492.985 |
| 12:34 ET | 309 | 493 |
| 12:36 ET | 4147 | 492.91 |
| 12:38 ET | 1806 | 493 |
| 12:41 ET | 200 | 493.5 |
| 12:43 ET | 900 | 493 |
| 12:45 ET | 800 | 492.71 |
| 12:48 ET | 674 | 492.75 |
| 12:52 ET | 3162 | 492.74 |
| 12:54 ET | 4515 | 492 |
| 12:56 ET | 100 | 492 |
| 12:57 ET | 1900 | 492.29 |
| 12:59 ET | 400 | 492.49 |
| 01:01 ET | 1983 | 492.82 |
| 01:03 ET | 1200 | 493 |
| 01:08 ET | 300 | 493.555 |
| 01:10 ET | 200 | 493.59 |
| 01:12 ET | 494 | 493.62 |
| 01:14 ET | 2024 | 493.5 |
| 01:15 ET | 500 | 493.44 |
| 01:17 ET | 800 | 493.44 |
| 01:19 ET | 1775 | 493.265 |
| 01:21 ET | 1122 | 493.5 |
| 01:24 ET | 200 | 493.7 |
| 01:26 ET | 1909 | 493.73 |
| 01:28 ET | 600 | 493.59 |
| 01:30 ET | 1300 | 493.1 |
| 01:32 ET | 100 | 493.16 |
| 01:33 ET | 3481 | 492.775 |
| 01:35 ET | 1500 | 492.805 |
| 01:37 ET | 900 | 492.89 |
| 01:39 ET | 800 | 492.875 |
| 01:42 ET | 200 | 492.91 |
| 01:44 ET | 782 | 492.82 |
| 01:46 ET | 3700 | 493.1458 |
| 01:48 ET | 819 | 492.43 |
| 01:50 ET | 200 | 492.26 |
| 01:51 ET | 600 | 492.355 |
| 01:53 ET | 2884 | 492.745 |
| 01:55 ET | 1992 | 492.5375 |
| 01:57 ET | 400 | 492.5 |
| 02:00 ET | 1700 | 492.465 |
| 02:02 ET | 600 | 492.51 |
| 02:04 ET | 500 | 492.5 |
| 02:06 ET | 1100 | 492.51 |
| 02:08 ET | 1174 | 492.485 |
| 02:09 ET | 800 | 492.465 |
| 02:11 ET | 1128 | 492.555 |
| 02:13 ET | 200 | 492.38 |
| 02:15 ET | 500 | 492.23 |
| 02:18 ET | 2437 | 492.2827 |
| 02:20 ET | 700 | 492 |
| 02:22 ET | 602 | 492 |
| 02:24 ET | 1585 | 492.245 |
| 02:26 ET | 2683 | 492.21 |
| 02:27 ET | 901 | 492.18 |
| 02:29 ET | 811 | 492.33 |
| 02:31 ET | 3629 | 492.85 |
| 02:33 ET | 1558 | 493.305 |
| 02:36 ET | 3059 | 493.45 |
| 02:38 ET | 2109 | 493.475 |
| 02:40 ET | 2012 | 493.115 |
| 02:42 ET | 528 | 493.1499 |
| 02:44 ET | 500 | 493.1 |
| 02:45 ET | 1080 | 493.31 |
| 02:47 ET | 800 | 493.68 |
| 02:49 ET | 1300 | 494.0467 |
| 02:51 ET | 700 | 494.15 |
| 02:54 ET | 1912 | 493.86 |
| 02:56 ET | 100 | 493.69 |
| 02:58 ET | 856 | 493.735 |
| 03:00 ET | 400 | 493.74 |
| 03:02 ET | 900 | 493.87 |
| 03:03 ET | 1074 | 493.595 |
| 03:05 ET | 700 | 493.51 |
| 03:07 ET | 2422 | 493.915 |
| 03:09 ET | 1700 | 494.39 |
| 03:12 ET | 2216 | 493.945 |
| 03:14 ET | 600 | 494.11 |
| 03:16 ET | 200 | 494.02 |
| 03:18 ET | 1500 | 493.275 |
| 03:20 ET | 440 | 493.09 |
| 03:21 ET | 500 | 493.315 |
| 03:23 ET | 789 | 493.295 |
| 03:25 ET | 2300 | 493.67 |
| 03:27 ET | 2200 | 493.435 |
| 03:30 ET | 2224 | 493.49 |
| 03:32 ET | 1105 | 493.53 |
| 03:34 ET | 1975 | 493.6835 |
| 03:36 ET | 1400 | 493.565 |
| 03:38 ET | 736 | 493.37 |
| 03:39 ET | 1467 | 493 |
| 03:41 ET | 1701 | 493.1 |
| 03:43 ET | 3147 | 492.865 |
| 03:45 ET | 2603 | 492.52 |
| 03:48 ET | 2110 | 492.22 |
| 03:50 ET | 3061 | 492.36 |
| 03:52 ET | 7320 | 492.5 |
| 03:54 ET | 6051 | 492.24 |
| 03:56 ET | 8300 | 491.25 |
| 03:57 ET | 3619 | 490.665 |
| 03:59 ET | 156136 | 490.85 |
Yesterday
DJ Vertex Sues U.S. to Pay for Fertility Treatments, from 9 hours ago by Dow Jones
9 hours ago by Dow JonesHealth Canada Grants Marketing Authorization for TRIKAFTA (elexacaftor/tezacaftor/ivacaftor and ivacaftor) for People With Cystic Fibrosis Aged 2 Years and Older With Certain Rare Mutations, from 16 hours ago by Dow Jones
16 hours ago by Dow Jones
Jul 11, 2024
DJ Vertex Pharmaceuticals Is Maintained at Equal-Weight by Morgan Stanley, from 1:20PM ET on Thursday Jul 11, 2024 by Dow Jones
1:20PM ET on Thursday Jul 11, 2024 by Dow Jones
Jul 2, 2024
DJ Vertex Gets Speedy FDA Review of Vanza Triple Cystic Fibrosis Therapy, from 8:59AM ET on Tuesday Jul 02, 2024 by Dow Jones
8:59AM ET on Tuesday Jul 02, 2024 by Dow JonesVertex Announces FDA Acceptance of New Drug Application for Vanzacaftor/Tezacaftor/Deutivacaftor, a Next-In-Class Triple Combination Treatment for Cystic Fibrosis, from 8:33AM ET on Tuesday Jul 02, 2024 by Dow Jones
8:33AM ET on Tuesday Jul 02, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Vertex Pharmaceuticals Inc | 126.1B | 31.8x | +46.35% |
Regeneron Pharmaceuticals Inc | 121.2B | 32.0x | +10.93% |
Biogen Inc | 33.5B | 27.7x | -18.14% |
Moderna Inc | 46.5B | -7.8x | --- |
ICON PLC | 27.8B | 41.4x | +4.68% |
IQVIA Holdings Inc | 40.8B | 30.8x | +46.62% |
Company Information
Vertex Pharmaceuticals Incorporated is a global biotechnology company. The Company is focused on investing in scientific innovation to create transformative medicines for people with serious diseases, with a focus on specialty markets. It has four approved medicines that treat the underlying cause of cystic fibrosis (CF), and one approved therapy that treats severe sickle cell disease (SCD) and transfusion dependent beta thalassemia (TDT). Its pipeline includes clinical-stage programs in CF, SCD, TDT, acute and neuropathic pain, APOL1-mediated kidney disease, type 1 diabetes, myotonic dystrophy type 1 and alpha-1 antitrypsin deficiency. Its marketed medicines are TRIKAFTA/KAFTRIO, SYMDEKO/SYMKEVI (tezacaftor/ivacaftor and ivacaftor), ORKAMBI (lumacaftor/ivacaftor) and KALYDECO (ivacaftor). It is developing non-autologous (allogeneic) fully differentiated, stem-cell derived islet cell therapies designed to replace insulin-producing islet cells that are destroyed in people with T1D.
Contact Information
- Headquarters
- 50 Northern AvenueBOSTON, MA, United States 02210
- Phone
- 617-341-6393
- Fax
- ---
Executives
- Executive Chairman of the Board
- Jeffrey Leiden
- President, Chief Executive Officer, Director
- Reshma Kewalramani
- Chief Financial Officer, Executive Vice President
- Charles Wagner
- Chief Operating Officer, Executive Vice President
- Stuart Arbuckle
- Executive Vice President - Global Research, Chief Scientific Officer
- David Altshuler
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $126.1B |
|---|---|
Revenue (TTM) | $10.2B |
Shares Outstanding | 258.1M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.39 |
EPS | $15.42 |
Book Value | $68.22 |
P/E Ratio | 31.8x |
Price/Sales (TTM) | 12.4 |
Price/Cash Flow (TTM) | 29.9x |
Operating Margin | 41.16% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
